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Background
Corticosteroid injection to the Temporo-Mandibular
(TMJ) joint in children with Juvenile Idiopathic Arthritis
(JIA) has been shown to be effective, but debate con-
tinues whether radiological guidance for needle place-
ment produces better outcomes.
Aim
To review clinical outcomes following TMJ injection
without radiological guidance.
Methods
All patients having TMJ injections (Triamcinolone Acet-
onide or Hexacetonide) in 2003-2009 were identified.
Injections were performed under general anaesthesia.
Notes were retrospectively reviewed looking at: symp-
toms, response to treatment, and examination findings
(jaw deviation, jaw opening, and micrognathia).
Results
47 patients (59% female) had a total of 71 joints
injected. Pain and reduced jaw opening were the most
common preceding symptoms. Mean age at JIA diagno-
sis was 9.3 years, and at time of TMJ injection was 12.8.
Mean time between JIA diagnosis and first TMJ injec-
tion ranged from 0.9-14.5years. JIA subtypes were: oli-
goarticular (18.6%), extended-oligoarticular (16.5%),
polyarticular (37.2%), enthesitis-related (9.3%), and psor-
iatic (18.6%). At the time of TMJ injection 18 patients
were receiving methotrexate, 4 prednisolone, 1 etaner-
cept and 1 leflunomide.
3 months after TMJ injection, 51% had complete resolu-
tion of symptoms, 44% had improved and 5% had no
response. 36 patients had follow-up data at a mean of 2.5
years, showing complete resolution of symptoms in 29/36
(80.5%), improvement in 3/36 (8.3%) and no improvement
in 4/36 (11.2%). No cases of micrognathia, Cushing’s syn-
drome, or subcutaneous atrophy were documented.
Conclusions
In this retrospective series corticosteroid injection of the
TMJ without radiologically-guided needle placement,
was a safe and effective treatment with no adverse side-
effects documented.
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